Daina Graybosch, Ph.D.

Daina Graybosch, Ph.D., is a Senior Research Analyst at Leerink Partners covering Immuno-Oncology.

Prior to joining the Firm in 2018, Dr. Graybosch worked at McKinsey & Company as a Senior Expert and Head of McKinsey’s Center for Asset Optimization, as well as the U.S. Head of the McKinsey Cancer Center. In these roles, Dr. Graybosch developed several McKinsey solutions that applied data and advanced analytics to pharmaceutical development decisions. During her 11 years at McKinsey, Dr. Graybosch built deep oncology expertise through work with companies across the pharmaceutical, diagnostic, academic medical center, and genomic/data sectors.

Dr. Graybosch earned dual B.S. degrees in Biology and Chemistry from the University of Utah and a Ph.D. in Chemistry and Chemical Biology from Harvard University.